Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan

ClinicalTrials.gov ID: NCT00016978

Public ClinicalTrials.gov record NCT00016978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 7:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Oxaliplatin (OXAL), 5-Fluorouracil (5-FU), and Leucovorin (CF) in Patients With Metastatic Colorectal Carcinoma Previously Treated With Irinotecan (CPT-11)

Study identification

NCT ID
NCT00016978
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
40 participants

Conditions and interventions

Interventions

  • FOLFOX regimen Drug
  • fluorouracil Drug
  • leucovorin calcium Drug
  • oxaliplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2001
Primary completion
May 31, 2007
Completion
Not listed
Last update posted
Feb 4, 2013

Started 2001

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
CCOP - Scottsdale Oncology Program Scottsdale Arizona 85259-5404
CCOP - Illinois Oncology Research Association Peoria Illinois 61602
CCOP - Carle Cancer Center Urbana Illinois 61801
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206
Oncology Associates of Cedar Rapids Cedar Rapids Iowa 52403
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733
CCOP - Wichita Wichita Kansas 67214-3882
CCOP - Ochsner New Orleans Louisiana 70121
CCOP - Ann Arbor Regional Ann Arbor Michigan 48106
CCOP - Duluth Duluth Minnesota 55805
Mayo Clinic Cancer Center Rochester Minnesota 55905
CentraCare Clinic Saint Cloud Minnesota 56303
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131
Medcenter One Health System Bismarck North Dakota 58501
CCOP - Merit Care Hospital Fargo North Dakota 58122
Altru Health Systems Grand Forks North Dakota 58201
CCOP - Toledo Community Hospital Oncology Program Toledo Ohio 43623-3456
CCOP - Sooner State Tulsa Oklahoma 74136
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001
Rapid City Regional Hospital Rapid City South Dakota 57709
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57105-1080

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00016978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2013 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00016978 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →